Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs LifeStance Health Group Inc. Common Stock (LFST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs LifeStance Health Group Inc. Common Stock — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $107.83 (market cap $8.88B), while LifeStance Health Group Inc. Common Stock trades at $12.49 (market cap $4.76B). The key difference: Kymera Therapeutics Inc. Common Stock is the larger of the two by market cap, and LifeStance Health Group Inc. Common Stock is trading nearer its 52-week high, Kymera Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and LifeStance Health Group Inc. Common Stock for 6 Days on average.
| KYMR | LFST | |
|---|---|---|
Market Cap | $8.88B | $4.76B |
Volume | 1,028,790 | 3,444,549 |
Sector | Health | Health |
52-Week High | $127.31 | $13.38 |
52-Week Low | $55.80 | $4.81 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $8.27B | $4.99B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
LifeStance Health Group (LFST) trades at $12.32, down 1.28% today, with strong technical momentum showing a bullish moving average signal. The company has consistently beaten earnings expectations in recent quarters, with Q2 2026 EPS of $0.06 exceeding the $0.03 forecast. Revenue growth accelerated from $1.42B in 2025 to $1.6B in 2026, while net income improved significantly from $9.66M to $51M.
Wall Street maintains strong bullish sentiment with 82% buy ratings and a $14.14 consensus price target representing 15% upside. However, elevated valuation multiples (P/E 94.8) and overbought technical conditions near 52-week highs warrant caution. The mental healthcare provider benefits from industry tailwinds but faces execution risks amid competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About LifeStance Health Group Inc. Common Stock
LifeStance Health provides outpatient mental healthcare, including therapy, psychiatry, and medication management services.
Read more on LFST →
